Orot Luces

About The Fund

Orot Luces is a venture capital firm based in Tel Aviv, Israel, specializing in early-stage investments within the healthcare sector, with an emphasis on the fields of cancer care, diagnostics, and oncology. They invest primarily in IT (& TMT), BioTech, and Life Sciences, aiming to impact the future of healthcare by transforming cancer care with a focus on diagnosis, therapeutics, and digital health. They position themselves as a platform that provides a favorable risk/reward profile for investors and entrepreneurs developing breakthrough technologies that will significantly impact cancer care. Orot Luces sees the rising number of new cancer incidences and the constant increase in the population living with cancer as an opportunity for value creation and impact, emphasizing significant unmet needs and recent advances in science and technology, alongside favorable regulatory frameworks which facilitate faster value creation and clear exit strategies. The firm rests on its direct acquaintance and access to global networks, hands-on professional management, and a claim of over four decades of proven track record in the healthcare field, establishing, operating, and profiting from businesses worth hundreds of millions of euros. Their dedicated team focuses on delivering favorable risk-adjusted returns across diverse healthcare services and biotech companies. Their fields of activity include diagnostics with genetic sequencing, metabolic profiling, early detection, therapeutics with precision medicine, targeted therapies, and beyond the pill strategies like integrative oncology, digital health, and patient empowerment. Orot Luces benefits from Israel's position as a Start-up Nation Hub, leveraging a strong opportunity funnel in a dynamic business culture with few investors and VC players.